A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/5415 (2006.01) A61K 41/00 (2006.01) A61P 17/06 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2330995
Photodynamic therapy is a new therapeutic modality in dermatology involving the administration of a photosensitizer and its subsequent activation with visible light to destroy or alter the function of target cells or tissues. Toluidine blue i(TBO) is a non-toxic cationic dye of the phenothiazine family. We show that toluidine blue has potent phototoxic effect against malignant human T lymphocytes in vitro. Apoptosis (DNA fragmentation and cell death) was rapidly induced by TBO in Jurkat cells. Psoriasis is an inflammatory skin disease in which the role of T lymphocytes is well established. Extensive psoriasis could be an ideal indication for photodynamic therapy with whole body light exposure after systemic photosensitizer administration. The use of human psoriatic skin-grafted SCID mice has been proven useful and reliable in the study of novel therapeutic agents. The goal of this project is two-fold: 1) to determine the dose-range of systemically administered toluidine blue and light inducing a phototoxic reaction in mice 2) determine whether we can induce clinical remission or improvement using TBO-based PDT in SCID mice. Mice are administered TBO and irradiated with light. Psoriatic skin response to treatment is followed with serial clinical assessments. A dose in the µg range of TBO is to be administered systemically to psoriatic patients. Further, the potent apoptotic effect of TBO on activated lymphocytes T is indicative of a role of TBO for bone marrow purging. A concentration in the µmolar range of TBO is to be contacted with bone marrow cells.
Bissonnette Robert
Boushira Michele
Tremblay Jean-Francois
Viau Gilles
Bissonnette Robert
Boushira Michele
Goudreau Gage Dubuc
Innovaderm Recherches Inc.
Tremblay Jean-Francois
LandOfFree
Toluidine blue-based photodynamic therapy for inducing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Toluidine blue-based photodynamic therapy for inducing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Toluidine blue-based photodynamic therapy for inducing... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2031403